Sign In
Buy NVO
$47.64
+0.230 (+0.485%)
At Close: Jun 25, 2026
Novo Nordisk: Can CagriSema Show 25% Weight Loss In REDEFINE-1 Trial?
11:28pm, Sunday, 24'th Nov 2024
Novo Nordisk will report the topline results from the REDEFINE-1 trial of CagriSema in obese patients before the end of the year. Management expects CagriSema to generate 25% weight loss after 68 week
EU antitrust regulators set to okay $16.5 bln Novo Holdings, Catalent deal, source says
12:37pm, Friday, 22'nd Nov 2024
EU antitrust regulators are set to clear without conditions Novo Holdings' planned $16.5 billion takeover of Catalent , a person with direct knowledge of the matter said on Friday.
Novo Nordisk Plunges 25% in 3 Months: How to Play the Stock
12:31pm, Friday, 22'nd Nov 2024
Despite the current downward trend of NVO, it is a good stock to retain in one's portfolio for long-term gains due to strong demand for its GLP-1 drugs.
Franklin International Equity Fund Q3 2024 Commentary
04:45am, Friday, 22'nd Nov 2024
Jinda Noipho Performance Data Average Annual Total Returns 4(%) 1 Mth 3 Mths 1 Year 3 Year 5 Year 10 Year Since Inception Inception Date Class C (MUTF:LMGEX) - With Sales Charges a -1.46 4.15 21.61 5.
Ypsomed will make injection pens for Novo Nordisk's CagriSema, says source
01:02am, Friday, 22'nd Nov 2024
Swiss medical technology company Ypsomed's contract with Novo Nordisk includes the supply of injection pens for the Danish drugmaker's next-generation experimental obesity drug CagriSema, a source fam
PFE vs. NVO: Which Stock Is the Better Value Option?
12:41pm, Thursday, 21'st Nov 2024
Investors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard of Pfizer (PFE) and Novo Nordisk (NVO). But which of these two stocks offers value investors a bett
Are Dietary Drug Stocks Eli Lilly and Novo Nordisk Ready To Rise Again?
08:31pm, Wednesday, 20'th Nov 2024
In today's article I will try to answer the question on whether the two premier diet drug companies stocks have finally stopped going down? I will look at two stocks (dietary drug is in parenthesis):
Is Novo Nordisk Stock a Buy Right Now?
06:10am, Wednesday, 20'th Nov 2024
Novo Nordisk stock has been pretty volatile lately, making it hard to judge whether now is a good opportunity to buy shares.
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
08:33am, Tuesday, 19'th Nov 2024
Bagsværd, Denmark, 19 November 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
04:01am, Tuesday, 19'th Nov 2024
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs of slowing down, much to the delight of its Danish manufacturer, Novo Nord
Medicaid dominates coverage of Novo, Lilly weight-loss drugs
12:11pm, Monday, 18'th Nov 2024
U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the reimbursement available from private employers and insurers, according to an ana
Novo Nordisk launches Wegovy weight drug in China at fraction of price
10:33am, Monday, 18'th Nov 2024
Novo Nordisk (NYSE:NVO) has begun rolling out its Wegovy weight loss drug in China at well below the price of the product in the US. A month's supply of the starter dose of Wegovy in China has been pr
Novo Nordisk A/S - share repurchase programme
10:08am, Monday, 18'th Nov 2024
Bagsværd, Denmark, 18 November 2024 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and
Novo Nordisk has launched obesity drug Wegovy in China
08:07am, Monday, 18'th Nov 2024
Novo Nordisk said on Monday it has launched its popular obesity drug Wegovy in China, the world's second-largest pharmaceuticals market.
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
06:03am, Monday, 18'th Nov 2024
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
